Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Reexamination Certificate
2005-08-23
2005-08-23
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
C530S331000, C549S213000, C562S007000, C514S018700, C514S019300
Reexamination Certificate
active
06933290
ABSTRACT:
Disclosed are derivatives of 2-{[N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl]-amino}-alkylboronic acid, processes for the preparation of such compounds, pharmaceutical preparations, and the use of such derivatives in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans
REFERENCES:
patent: 4499082 (1985-02-01), Shenvi et al.
patent: 5106948 (1992-04-01), Kinder et al.
patent: 5169841 (1992-12-01), Kleeman et al.
patent: 5384410 (1995-01-01), Kettner
patent: 5550262 (1996-08-01), Iqbal et al.
patent: 5614649 (1997-03-01), Iqbal et al.
patent: 5658885 (1997-08-01), Lee et al.
patent: 5780454 (1998-07-01), Adams et al.
patent: 6066730 (2000-05-01), Adams et al.
patent: 6083903 (2000-07-01), Adams et al.
patent: 6297217 (2001-10-01), Adams et al.
patent: 2001/0012854 (2001-08-01), Siman et al.
patent: 145 441 (1985-06-01), None
patent: 315 574 (1989-05-01), None
patent: 471 651 (1992-02-01), None
patent: 94/21668 (1994-09-01), None
patent: 94 25049 (1994-11-01), None
patent: 96 12499 (1996-05-01), None
Adams, J. et al.: Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg. & Medicin. Chem. Lett. vol. 8, pp. 333-338, 1998.
Proteasome Inhibitor Program, Cephalon, Inc., Jul. 2001.
Internal Search Memo by Vera Stanek, Jan. 11, 2002.
Adams, Julian et al., “Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids,” Bioorganic & Medicinal Chemistry Letters 8(4), pp. 333-338 (1998), Missing BR, BS.
Christie, G, et al., “Alzheimer's disease: correlation of the suppression of .beta.-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome,” Journal of Neurochemistry, 73(1), pp. 195-204 (1999), Missing BR, BS.
Furet Pascal
Guagnano Vito
Imbach Patricia
Lang Marc
Aulakh Charanjit S.
McNally Lydia T.
Novartis AG
LandOfFree
2-{N-(2-amino-3-(heteroaryl or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-{N-(2-amino-3-(heteroaryl or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-{N-(2-amino-3-(heteroaryl or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3500767